Thyroid hormones, T3 and T4, in the brain

Frontiers in Endocrinology

Volumn 5, Issue MAR, 2014, Pages

  Schroeder, Amy C ^a   Privalsky, Martin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; Coregulator; Deiodinase 2; Thyroid hormone receptor

Indexed keywords

HORMONE RECEPTOR STIMULATING AGENT; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; ORGANIC ANION TRANSPORTER F; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PROTIRELIN; STEROID RECEPTOR COACTIVATOR 1; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN TISSUE; GENETIC TRANSCRIPTION; HORMONE BINDING; HORMONE TRANSPORT; HUMAN; HYPOTHYROIDISM; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; REVIEW; THYROID HORMONE SYNTHESIS;

EID: 84901036696     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00040     Document Type: Review

References (61)

1. Morreale de Escobar G, Obregon MJ, Escobar Del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol (2004) 151(Suppl 3):U25-37. doi:10.1530/eje.0.151U025.
2. Wallis K, Dudazy S, Van Hogerlinden M, Nordstrom K, Mittag J, Vennstrom B. The thyroid hormone receptor alpha1 protein is expressed in embryonic postmitotic neurons and persists in most adult neurons. Mol Endocrinol (2010) 24:1904-16. doi:10.1210/me.2010-0175.
3. Galton VA. The roles of the iodothyronine deiodinases in mammalian development. Thyroid (2005) 15:823-34. doi:10.1089/thy.2005.15.823.
4. Laurberg P. Thyroid function: thyroid hormones, iodine and the brain-an important concern. Nat Rev Endocrinol (2009) 5:475-6. doi:10.1038/nrendo.2009.155.
5. Arrojo EDR, Fonseca TL, Werneck-De-Castro JP, Bianco AC. Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim Biophys Acta (2013) 1830:3956-64. doi:10.1016/j.bbagen.2012.08.019.
6. DeLong GR, Stanbury JB, Fierro-Benitez R. Neurological signs in congenital iodine-deficiency disorder (endemic cretinism). Dev Med Child Neurol (1985) 27:317-24. doi:10.1111/j.1469-8749.1985.tb04542.x.
7. Thompson CC, Potter GB. Thyroid hormone action in neural development. Cereb Cortex (2000) 10:939-45. doi:10.1093/cercor/10.10.939.
8. Quignodon L, Legrand C, Allioli N, Guadano-Ferraz A, Bernal J, Samarut J, et al. Thyroid hormone signaling is highly heterogeneous during pre-and postnatal brain development. J Mol Endocrinol (2004) 33:467-76. doi:10.1677/jme.1.01570.
9. Gereben B, Zeold A, Dentice M, Salvatore D, Bianco AC. Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell Mol Life Sci (2008) 65:570-90. doi:10.1007/s00018-007-7396-0.
10. St Germain DL, Galton VA, Hernandez A. Minireview: defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology (2009) 150:1097-107. doi:10.1210/en.2008-1588.
11. Yen PM. Thorough physiological review-physiological and molecular basis of thyroid hormone action. Physiol Rev (2001) 81:1097-142.
12. Sandler B, Webb P, Apriletti JW, Huber BR, Togashi M, Cunha Lima ST, et al. Thyroxine-thyroid hormone receptor interactions. J Biol Chem (2004) 279:55801-8. doi:10.1074/jbc. M410124200.
13. Larsen PR, Davies TF, Schlumberger M-J, Hay ID. Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Williams Textbook of Endocrinology. Philadelphia: Saunders (2003). p. 331-73.
14. Galton VA. The role of 3,5,3'-triiodothyronine in the physiological action of thyroxine in the premetamorphic tadpole. Endocrinology (1989) 124:2427-33. doi:10.1210/endo-124-5-2427.
15. Zimmermann MB. The impact of iodised salt or iodine supplements on iodine status during pregnancy, lactation and infancy. Public Health Nutr (2007) 10:1584-95. doi:10.1017/S1368980007360965.
16. de Escobar GM, Ares S, Berbel P, Obregon MJ, Del Rey FE. The changing role of maternal thyroid hormone in fetal brain development. Semin Perinatol (2008) 32:380-6. doi:10.1053/j.semperi.2008.09.002.
17. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid (2011) 21:1081-125. doi:10.1089/thy.2011.0087.
18. Crantz FR, Silva JE, Larsen PR. An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology (1982) 110:367-75. doi:10.1210/endo-110-2-367.
19. Heuer H. The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab (2007) 21:265-76. doi:10.1016/j.beem.2007.03.003.
20. Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab (2009) 297:E1238-46. doi:10.1152/ajpendo.00480.2009.
21. O'Shea PJ, Williams GR. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol (2002) 175:553-70. doi:10.1677/joe.0.1750553.
22. Williams RH, Larsen PR. Williams Textbook of Endocrinology. Philadelphia, PA: Saunders (2003).
23. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem (2003) 278:40128-35. doi:10.1074/jbc. M300909200.
24. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol (2008) 22:1357-69. doi:10.1210/me.2007-0112.
25. Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest (2006) 116:2571-9. doi:10.1172/JCI29812.
26. Chan SY, Vasilopoulou E, Kilby MD. The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metab (2009) 5:45-54. doi:10.1038/ncpendmet1026.
27. Galton VA, Schneider MJ, Clark AS, St Germain DL. Life without thyroxine to 3,5,3'-triiodothyronine conversion: studies in mice devoid of the 5'-deiodinases. Endocrinology (2009) 150:2957-63. doi:10.1210/en.2008-1572.
28. Rodriguez EM, Gonzalez CB, Delannoy L. Cellular organization of the lateral and postinfundibular regions of the median eminence in the rat. Cell Tissue Res (1979) 201:377-408. doi:10.1007/BF00236998.
29. Tu HM, Kim SW, Salvatore D, Bartha T, Legradi G, Larsen PR, et al. Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology (1997) 138:3359-68. doi:10.1210/endo.138.8.5318.
30. Guadano-Ferraz A, Escamez MJ, Rausell E, Bernal J. Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. J Neurosci (1999) 19:3430-9.
31. Calvo R, Obregon MJ, Ruiz De Ona C, Escobar Del Rey F, Morreale de Escobar G. Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3'-triiodothyronine in the protection of the fetal brain. J Clin Invest (1990) 86:889-99. doi:10.1172/JCI114790.
32. Dratman MB, Crutchfield FL, SchoenhoffMB. Transport of iodothyronines from bloodstream to brain: contributions by blood:brain and choroid plexus:cerebrospinal fluid barriers. Brain Res (1991) 554:229-36. doi:10.1016/0006-8993(91)90194-Z.
33. Chatonnet F, Picou F, Fauquier T, Flamant F. Thyroid hormone action in cerebellum and cerebral cortex development. J Thyroid Res (2011) 2011:145762. doi:10.4061/2011/145762.
34. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia (2010) 58:1094-103. doi:10.1002/glia.20990.
35. Lazar MA, Berrodin TJ, Harding HP. Differential DNA binding by monomeric, homodimeric, and potentially heteromeric forms of the thyroid hormone receptor. Mol Cell Biol (1991) 11:5005-15.
36. Naar AM, Boutin JM, Lipkin SM, Yu VC, Holloway JM, Glass CK, et al. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell (1991) 65:1267-79. doi:10.1016/0092-8674(91)90021-P.
37. Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH. Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol Endocrinol (1992) 6:429-42. doi:10.1210/mend.6.3.1316541.
38. Wahlstrom GM, Sjoberg M, Andersson M, Nordstrom K, Vennstrom B. Binding characteristics of the thyroid hormone receptor homo-and heterodimers to consensus AGGTCA repeat motifs. Mol Endocrinol (1992) 6:1013-22. doi:10.1210/me.6.7.1013.
39. Kurokawa R, Yu VC, Naar A, Kyakumoto S, Han Z, Silverman S, et al. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev (1993) 7:1423-35. doi:10.1101/gad.7.7b.1423.
40. Privalsky ML, Lee S, Hahm JB, Young BM, Fong RN, Chan IH. The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors. J Biol Chem (2009) 284:19554-63. doi:10.1074/jbc. M109.007542.
41. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev (2010) 31:139-70. doi:10.1210/er.2009-0007.
42. Rosen MD, Privalsky ML. Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity. Mol Endocrinol (2009) 23:1183-92. doi:10.1210/me.2009-0126.
43. Chan IH, Privalsky ML. Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1. Mol Endocrinol (2009) 23:1758-75. doi:10.1210/me.2009-0025.
44. Chatonnet F, Guyot R, Benoit G, Flamant F. Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells. Proc Natl Acad Sci U S A (2013) 110:E766-75. doi:10.1073/pnas.1210626110.
45. Murata Y. Multiple isoforms of thyroid hormone receptor: an analysis of their relative contribution in mediating thyroid hormone action. Nagoya J Med Sci (1998) 61:103-15.
46. Forrest D, Vennstrom B. Functions of thyroid hormone receptors in mice. Thyroid (2000) 10:41-52. doi:10.1089/thy.2000.10.41.
47. Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annu Rev Physiol (2000) 62:439-66. doi:10.1146/annurev.physiol.62.1.439.
48. Wondisford FE. Thyroid hormone action: insight from transgenic mouse models. J Investig Med (2003) 51:215-20. doi:10.2310/6650.2003.39191.
49. Cheng SY. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice. Steroids (2005) 70:450-4. doi:10.1016/j.steroids.2005.02.003.
50. Flamant F, Samarut J. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab (2003) 14:85-90. doi:10.1016/S1043-2760(02)00043-7.
51. Schwartz HL, Strait KA, Ling NC, Oppenheimer JH. Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J Biol Chem (1992) 267:11794-9.
52. Heuer H, Mason CA. Thyroid hormone induces cerebellar Purkinje cell dendritic development via the thyroid hormone receptor alpha1. J Neurosci (2003) 23:10604-12.
53. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, Galton VA. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol (2001) 15:2137-48. doi:10.1210/me.15.12.2137.
54. Liao XH, Di Cosmo C, Dumitrescu AM, Hernandez A, Van Sande J, St Germain DL, et al. Distinct roles of deiodinases on the phenotype of MCT8 defect: a comparison of eight different mouse genotypes. Endocrinology (2011) 152:1180-91. doi:10.1210/en.2010-0900.
55. Morte B, Ceballos A, Diez D, Grijota-Martinez C, Dumitrescu AM, Di Cosmo C, et al. Thyroid hormone-regulated mouse cerebral cortex genes are differentially dependent on the source of the hormone: a study in monocarboxylate transporter-8-and deiodinase-2-deficient mice. Endocrinology (2010) 151:2381-7. doi:10.1210/en.2009-0944.
56. Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, et al. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology (2008) 149:6251-61. doi:10.1210/en.2008-0378.
57. Ceballos A, Belinchon MM, Sanchez-Mendoza E, Grijota-Martinez C, Dumitrescu AM, RefetoffS, et al. Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3'-triiodo-l-thyronine. Endocrinology (2009) 150:2491-6. doi:10.1210/en.2008-1616.
58. Hernandez A, Morte B, Belinchon MM, Ceballos A, Bernal J. Critical role of types 2 and 3 deiodinases in the negative regulation of gene expression by T(3)in the mouse cerebral cortex. Endocrinology (2012) 153:2919-28. doi:10.1210/en.2011-1905.
59. Ferrara AM, Liao XH, Gil-Ibanez P, Marcinkowski T, Bernal J, Weiss RE, et al. Changes in thyroid status during perinatal development of MCT8-deficient male mice. Endocrinology (2013) 154:2533-41. doi:10.1210/en.2012-2031.
60. Iannacone EA, Yan AW, Gauger KJ, Dowling AL, Zoeller RT. Thyroid hormone exerts site-specific effects on SRC-1 and NCoR expression selectively in the neonatal rat brain. Mol Cell Endocrinol (2002) 186:49-59. doi:10.1016/S0303-7207(01)00672-4.
61. Galeeva A, Treuter E, Tuohimaa P, Pelto-Huikko M. Comparative distribution of the mammalian mediator subunit thyroid hormone receptor-associated protein (TRAP220) mRNA in developing and adult rodent brain. Eur J Neurosci (2002) 16:671-83. doi:10.1046/j.1460-9568.2002.02115.x.